|Bid||0.00 x 800|
|Ask||0.00 x 1000|
|Day's Range||244.87 - 247.60|
|52 Week Range||226.15 - 267.37|
|Beta (5Y Monthly)||0.76|
|PE Ratio (TTM)||38.61|
|Earnings Date||Nov 04, 2021|
|Forward Dividend & Yield||3.32 (1.35%)|
|Ex-Dividend Date||Sep 08, 2021|
|1y Target Est||268.13|
Subscribe to Yahoo Finance Plus to view Fair Value for BDXLearn more
Continued strength in BD's (BDX) Life Sciences and Interventional segments is expected to have driven up Q4 sales.
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it will host a virtual investor day on Friday, Nov. 12, 2021 at 8 a.m., which will last for approximately four hours. The event will feature presentations from Tom Polen, chairman, chief executive officer and president of the company, and other key members of the executive leadership team. Question and answer sessions will follow the presentations.
Becton Dickinson and Co (NYSE: BDX) has partnered with Amazon.com Inc (NASDAQ: AMZN) to begin shipment of a new at-home rapid COVID-19 test that can confirm results using an entirely automated smartphone app. The BD Veritor At-Home COVID-19 Test, which U.S. regulators authorized in August, also automatically reports results to federal and state public health authorities. Related Link: BD Locks FDA Emergency Use Nod For At-Home COVID-19 Antigen Test. The test uses the Scanwell Health mobile app t